ConductScience.org, home

Paper3972295

Prognostic factors in carcinoma of the vulva.

Boyce J and 5 others. Gynecol Oncol, 1985. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Prognostic factors in carcinoma of the vulva. Papers, record 3972295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3972295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic factors in carcinoma of the vulva.
PubMed
Journal
Gynecol Oncol
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
3.82
iCite
Revised in PubMed
2019-08-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boyce JJ
2Fruchter RGR G
3Kasambilides EE
4Nicastri ADA D
5Sedlis AA
6Remy JCJ C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Vulvar NeoplasmsMajor topic
Clitoris
Female
Groin
Humans
Lymphatic Metastasis
Neoplasm Invasiveness
Prognosis
Vulva

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
41514316Risk stratification of groin node metastases in vulvar cancer biopsies based on histology and immunohistochemical staining.J Gynecol Oncol2026https://conductscience.org/library/papers/41514316PubMed
35053582Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study.Cancers (Basel)2022https://conductscience.org/library/papers/35053582PubMed
33723714Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.Ann Surg Oncol2021https://conductscience.org/library/papers/33723714PubMed
33293730Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Geburtshilfe Frauenheilkd2020https://conductscience.org/library/papers/33293730PubMed
29386916Vulvar carcinoma: dilemma, debates, and decisions.Cancer Manag Res2018https://conductscience.org/library/papers/29386916PubMed
24970683Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24970683PubMed
24672200Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.J Midlife Health2014https://conductscience.org/library/papers/24672200PubMed
23351240Prognostic analysis of early-stage squamous cell carcinoma of the vulva.World J Surg Oncol2013https://conductscience.org/library/papers/23351240PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3972295

GET https://conductscience.org/api/papers/v1/3972295/authors